Claims for Patent: 8,470,337
✉ Email this page to a colleague
Summary for Patent: 8,470,337
Title: | Therapeutic treatments using botulinum neurotoxin |
Abstract: | Methods for treating a coronary risk factor (such as hypertension, diabetes, hyperlipidemia and obesity) and/or a respiratory disorder (such as asthma, chronic obstructive pulmonary disease and bronchitis) and/or arthritis by local administration of a botulinum neurotoxin to at least one of a head, neck or shoulder location (for example, by subdermal, subcutaneous or intramuscular administration of the botulinum neurotoxin) of a patient with a coronary risk factor, respiratory disorder or arthritis. |
Inventor(s): | Manack; Aubrey N. (Costa Mesa, CA), Brin; Mitchell F. (Newport Beach, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 12/047,482 |
Patent Claims: | 1. A method for treating osteoarthritis pain in a patient in need thereof, the method comprising the step of intramuscular administration of a therapeutically effective
amount of botulinum toxin bilaterally to the splenius capitis and temporalis muscles of a patient suffering osteoarthritis pain, thereby decreasing the osteroarthritis pain.
2. The method of claim 1 wherein the botulinum neurotoxin is botulinum neurotoxin type A. 3. The method of claim 1, wherein the osteoarthritis pain experienced by the patient is experienced in a knee joint. 4. The method of claim 1, wherein the patient has no improvement with an oral medication. 5. The method of claim 4, wherein the oral medication is a non steroidal anti-inflammatory drug, COX-2 inhibitor, analgesics or a corticosteroid. 6. The method of claim 1, wherein the botulinum toxin administered is from about 5 units to about 2500 units of a botulinum toxin type A or from about 100 to about 25,000 units of a botulinum toxin type B. |
Details for Patent 8,470,337
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.